Abramson Cancer Center head and neck cancer clinicians and researchers are leading the way nationally in the diagnosis and treatment of head and neck cancers.
Today, there's more hope than ever for those who face cancer of the head and neck. Penn’s Head and Neck Cancer team have worked together for years caring for those with head and neck cancer.
By putting our experience to work, we offer the best possible treatment outcomes.
Penn established the world’s first TransOral Robotic Surgery (TORS) program. TORS is a minimally invasive, robotically-assisted surgical approach to removing tumors of the mouth, throat and voice box. It dramatically improves the treatment of head and neck cancers.
Penn researchers also led the study that established the first breakthrough, in thirty years, for thyroid cancer treatment.
If diagnosed with a head and neck cancer, or concerned about head and neck cancer, it’s important to have the best team of experts available.
Penn’s Multidisciplinary Center for Head and Neck Cancer has individuals, nationally and internationally, recognized for their expertise who can provide the information, care, and support to help each step of the way.
To learn about what sets us apart, visit:
Watch Focus on Head and Neck Cancer Conference - Get information on the latest advances in head and neck cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.
Watch Focus on Thyroid Cancer Conference - Get information on the latest advances in thyroid cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.
Clinical trials are studies to find new ways to prevent, detect and treat cancer. The purpose of each clinical trial is to answer a specific question. Our physicians carefully design these studies to find new ways to improve care and quality of life ...